Enhancing Skin Cancer Early Detection and Treatment in Primary Care

Study Overview
=================
Brief Summary
-----------------
Skin cancer screening may help find melanoma sooner, when it may be easier to treat. If found early melanoma and other types of skin cancer may be curable. Multi-component education may be an effective method to help primary care physicians (PCPs) learn about skin cancer screening. This clinical trial examines whether a clinician-focused educational intervention can improve PCP's knowledge and clinical performance to identify and triage skin cancer. This intervention may increase the PCP's ability to diagnose, treat and/or triage early-stage melanoma.

Detailed Description
-----------------
PRIMARY OBJECTIVE: I. Evaluate whether a multi-component education strategy improves the ability of PCPs to identify and triage skin cancer. OUTLINE: Participants are assigned to 1 of 2 groups. PCP participants complete group training and online training sessions. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview. PCPs at the two clinics who are in pods that are not assigned to receive the intervention will serve as study comparators. Comparison group has no direct exposure to the group or online training sessions.

Official Title
-----------------
Enhancing Skin Cancer Early Detection and Treatment in Primary Care

Conditions
-----------------
Cutaneous Melanoma

Intervention / Treatment
-----------------
* Behavioral: Training and Education


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Two Oregon Health & Science University (OHSU) primary care pods at two clinics will be assigned to receive exposure to the melanoma early detection intervention Clinicians at the two clinics who are in pods that are not assigned to receive the intervention will serve as study comparators These individuals are all aged 18 years or older All practice members speak English Exclusion Criteria: No one will be intentionally excluded

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Screening
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| No Intervention: Comparison group<br>PCPs at the two clinics who are in pods that are not assigned to receive the intervention will serve as study comparators. Comparison group has no exposure to the group or online training sessions. | |
| Experimental: Other, Pragmatic<br>PCP participants complete group training and online training sessions. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview. | Behavioral: Training and Education<br>* Undergo group and online trainings<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Reach of the educational intervention | Measured by proportion of clinicians invited to participate in the educational intervention that complete the training modules and utilize dot phases and smart tools in EHR | 6 months | 
| Clinician knowledge in screening for skin cancer | Change in knowledge based upon survey questions prior to training and post-training. | 6 months | 
| Use of risk assessment tool | Measured through electronic health record (EHR) data. | 18 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Identification of suspicious lesions | Measured through EHR data. | 18 months |